Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care.
Price
D B
DB
Thorpewood Surgery, Thorpe, Norwich, U.K.
Appleby
J L
JL
D000730:Androstadienes / Q000191:economics / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000191:economics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000191:economics / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D000068298:Fluticasone; D005938:Glucocorticoids / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D008485:Medical Audit; D011239:Prednisolone / Q000191:economics / Q000627:therapeutic use; D011320:Primary Health Care / Q000191:economics*; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone; D000068298:Fluticasone